CCR2 and familial pancreatic carcinoma: It has been a hotspot in inflammation-related diseases research, such as research on pancreatic cancer [21], liver cancer [22], and prostate cancer [23], and CCR2 antagonist can effectively alleviate the related diseases mediated by CCR2.